Nifty
:
22643.40
Sensex
:
74671.28
223.45 (1.00%)
941.12 (1.28%)
Nifty
Sensex
:
:
22643.40
74671.28
223.45 (1.00%)
941.12 (1.28%)

Sudarshan Pharma Industries Ltd.

Pharmaceuticals & Drugs

Rating :
61/99

BSE: 543828 | NSE: Not Listed

NSE BSE
79.56
29-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  76.50
  •  80.00
  •  75.01
  •  78.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  65
  •  86.96
  •  91.90
  •  62.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 191.47
  • 27.21
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 213.85
  • 0.38%
  • 1.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.39%
  • 13.08%
  • 23.62%
  • FII
  • DII
  • Others
  • 1.4%
  • 0.00%
  • 4.51%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Net Sales
-
461.33
357.09
193.35
Net Sales Growth
-
29.19%
84.69%
 
Cost Of Goods Sold
-
430.95
335.10
177.59
Gross Profit
-
30.38
21.99
15.76
GP Margin
-
6.59%
6.16%
8.15%
Total Expenditure
-
446.64
346.18
186.19
Power & Fuel Cost
-
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
Employee Cost
-
2.08
1.68
1.38
% Of Sales
-
0.45%
0.47%
0.71%
Manufacturing Exp.
-
4.56
2.80
1.70
% Of Sales
-
0.99%
0.78%
0.88%
General & Admin Exp.
-
3.96
2.75
2.01
% Of Sales
-
0.86%
0.77%
1.04%
Selling & Distn. Exp.
-
4.66
3.75
3.50
% Of Sales
-
1.01%
1.05%
1.81%
Miscellaneous Exp.
-
0.44
0.10
0.00
% Of Sales
-
0.10%
0.03%
0%
EBITDA
-
14.69
10.91
7.16
EBITDA Margin
-
3.18%
3.06%
3.70%
Other Income
-
1.12
0.46
0.38
Interest
-
5.40
3.38
3.23
Depreciation
-
0.91
0.87
0.74
PBT
-
9.50
7.14
3.57
Tax
-
2.46
1.89
0.90
Tax Rate
-
25.89%
26.47%
25.21%
PAT
-
7.04
5.25
2.67
PAT before Minority Interest
-
7.04
5.25
2.67
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
1.53%
1.47%
1.38%
PAT Growth
-
34.10%
96.63%
 
EPS
-
2.92
2.18
1.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Shareholder's Funds
100.97
29.78
22.51
Share Capital
24.07
9.75
9.55
Total Reserves
76.91
20.03
12.96
Non-Current Liabilities
13.03
5.12
5.48
Secured Loans
11.78
4.08
2.82
Unsecured Loans
1.01
0.86
2.50
Long Term Provisions
0.06
0.04
0.03
Current Liabilities
118.48
102.62
71.22
Trade Payables
91.89
73.75
44.22
Other Current Liabilities
7.53
4.89
5.34
Short Term Borrowings
18.35
23.59
21.38
Short Term Provisions
0.71
0.39
0.28
Total Liabilities
232.48
137.52
99.26
Net Block
19.89
6.47
6.21
Gross Block
22.45
8.49
7.64
Accumulated Depreciation
2.56
2.03
1.42
Non Current Assets
33.86
7.94
11.62
Capital Work in Progress
0.01
0.54
0.00
Non Current Investment
12.34
0.00
0.00
Long Term Loans & Adv.
1.62
0.94
5.40
Other Non Current Assets
0.00
0.00
0.00
Current Assets
198.62
129.58
87.64
Current Investments
0.00
0.00
0.00
Inventories
74.57
46.87
23.96
Sundry Debtors
81.51
73.48
60.39
Cash & Bank
11.72
0.24
1.25
Other Current Assets
30.83
0.45
0.43
Short Term Loans & Adv.
29.74
8.55
1.60
Net Current Assets
80.14
26.96
16.42
Total Assets
232.48
137.52
99.26

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-28.79
-3.82
2.77
PBT
9.50
7.14
3.57
Adjustment
5.82
4.05
3.94
Changes in Working Capital
-42.00
-13.24
-3.91
Cash after chg. in Working capital
-26.69
-2.05
3.61
Interest Paid
0.00
0.00
0.00
Tax Paid
-2.11
-1.77
-0.84
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-25.65
-1.46
-1.29
Net Fixed Assets
-13.43
-1.39
Net Investments
-12.34
-0.01
Others
0.12
-0.06
Cash from Financing Activity
65.93
4.26
-1.49
Net Cash Inflow / Outflow
11.48
-1.02
-0.01
Opening Cash & Equivalents
0.24
1.25
1.27
Closing Cash & Equivalent
11.72
0.24
1.25

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
41.96
30.54
23.58
ROA
3.80%
4.43%
2.69%
ROE
10.76%
20.08%
11.87%
ROCE
15.25%
18.67%
13.01%
Fixed Asset Turnover
29.82
44.28
25.32
Receivable days
61.31
68.42
114.01
Inventory Days
48.04
36.20
45.24
Payable days
70.15
64.25
90.88
Cash Conversion Cycle
39.21
40.37
68.37
Total Debt/Equity
0.34
1.03
1.32
Interest Cover
2.76
3.11
2.11

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.